Pfizer's JN.1 vaccine has been the only option available to Australians since the start of the year. Here's what happened to ...

Analysts are intrested in these 5 stocks: ( ($NU) ), ( ($AMAT) ), ( ($OKLO) ), ( ($NVAX) ) and ( ($SNOW) ). Here is a breakdown of their recent ...

As a summer COVID-19 surge hits Michigan, unanswered questions abound about eligibility, insurance coverage and when new ...

Bank of America’s downgrade to ‘Underperform’ with a $7 target deepened concerns over Sanofi’s limited commercialization of ...

BofA forecasts slowing overall revenue, estimating about $1 billion in 2025, slightly below the company’s guidance. It ...

Novavax (NVAX) downgraded to Underperform by BofA due to uncertain growth outlook despite cost-cutting measures. Read more ...

Novavax, Inc. (NASDAQ:NVAX) is one of the 11 Best Short Squeeze Stocks to Buy Now. The company’s non-mRNA COVID-19 vaccine is ...

If you want a COVID-19 shot this fall, will your employer’s health insurance plan pay for it? There’s no clear answer.

With so much in flux, it’s important to check with your employer or insurer about coverage policies before you roll up your ...

Pfizer (PFE) stock and BioNTech (BNTX) stock in focus as FDA may not renew the authorization for their pediatric COVID shot. Read more here.

Vinay Prasad returns as FDA's CBER director after brief exit, raising questions on rare disease drug approvals and mRNA ...

Federal health agencies responsible for spelling out who should get the COVID-19 vaccine this fall aren’t necessarily in sync. That has made it unclear whether health insurers will cover the shots.